Temazepam

Product NDC
70518-3093
11-digit product format
705183093
Labeler code
70518
Product ID
70518-3093_c238729d-a785-4155-e053-2995a90aade5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Temazepam
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA211542
Marketing category
ANDA
Marketing start
2021-05-11
Marketing end
0000-00-00
Substance
TEMAZEPAM
Active strength
23 mg/1
Pharmacologic classes
Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3093-02023-03-16C16284748780-1f386c64a-1bb5-0266-e053-dadaa90a7c1af11ea13c-3adc-4caf-83f2-6b036b75161c
70518-3093-02023-01-30C16284748780-1f386c64a-1bb5-0266-e053-dadaa90a7c1af11ea13c-3adc-4caf-83f2-6b036b75161c

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3093-07051830930030 CAPSULE in 1 BOTTLE, PLASTIC (70518-3093-0) 30 capsule2021-05-110000-00-00NoNoCurrent